Session Details

F030 Practice Management: Teledermatology Session

Sat, Mar 20, 1:00 PM - 3:00 PM
2 CME Available Forum Practice Management

DESCRIPTION

This session will explore the evolving landscape of virtual care delivery in dermatology, teaching participants key skills and best practices for leveraging innovative telemedicine modalities and platforms to optimize access to care, facilitate triage decisions, improve patient outcomes, and support health equity. Participants will learn about the various modes of virtual care, including live-interactive visits, online digital evaluation and management, interprofessional e-consults, inbox management and telepathology. Presenters will demonstrate how virtual care can be effectively implemented to expand practice reach and increase access to dermatologist-level care across wide-ranging practice models.

LEARNING OBJECTIVES

1.

Explain various modes of virtual care delivery (e.g., live-interactive, store-and-forward, e-consults, inbox management, telepathology) and review their optimal use in the practice of dermatology.

2.

Discuss and examine evidence for new teledermatology tools and virtual practice models to increase access to care, improve patient outcomes, optimize in-person care, and support health equity.

3.

Demonstrate efficient and effective virtual care models and workflows applicable in a variety of dermatology practice models.

DIRECTOR

Veena Vanchinathan, MD, FAAD

Veena Vanchinathan, MD, FAAD

SPEAKERS

Lia Gracey Maniar, MD, PhD, FAAD

Lia Gracey Maniar, MD, PhD, FAAD

Jules Lipoff, MD, FAAD

Jules Lipoff, MD, FAAD

Sara Harcharik Perkins, MD, FAAD

Sara Harcharik Perkins, MD, FAAD

Melanie Jane Tuerk, MD, FAAD

Melanie Jane Tuerk, MD, FAAD

Kaiser Permanente

DISCLOSURES

Lia Gracey Maniar, MD, PhD, FAAD

No financial relationships exist with ineligible companies.

Jules Lipoff, MD, FAAD

Amgen – Consultant (1099 relationship)(Fees); Guidepoint Global, LLC – Consultant(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); Takeda Pharmaceuticals USA Inc – Advisory Board(Fees); UpToDate – Other(Other Financial Benefit);

Sara Harcharik Perkins, MD, FAAD

Hims – Advisory Board(Fees);

Melanie Jane Tuerk, MD, FAAD

No financial relationships exist with ineligible companies.

Veena Vanchinathan, MD, FAAD

No financial relationships exist with ineligible companies.